[{"address1": "1400 Sierra Point Parkway", "address2": "Building C Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 822 5500", "fax": "650 636 9773", "website": "https://www.annexonbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barr\u00e9 syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.", "fullTimeEmployees": 100, "companyOfficers": [{"maxAge": 1, "name": "Mr. Douglas  Love Esq., J.D.", "age": 56, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 980122, "exercisedValue": 0, "unexercisedValue": 516039}, {"maxAge": 1, "name": "Dr. Dean R. Artis Ph.D.", "age": 63, "title": "Chief Scientific Officer & Executive VP", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 797380, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ted  Yednock Ph.D.", "age": 66, "title": "Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 697760, "exercisedValue": 0, "unexercisedValue": 119297}, {"maxAge": 1, "name": "Ms. Jennifer  Lew CPA", "age": 51, "title": "Executive VP, CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 624195, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Mr. Michael  Overdorf M.B.A.", "age": 54, "title": "Executive VP & Chief Business Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 580469, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Mr. Henk-Andre  Kroon M.D.", "title": "Senior Vice President of Translational Medicine", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jamie  Dananberg M.D.", "age": 66, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shikhar  Agarwal M.B.A.", "title": "Senior VP & Head of Commercial", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sunil  Mehta Pharm.D.", "title": "Senior VP of Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.83, "open": 1.76, "dayLow": 1.66, "dayHigh": 1.83, "regularMarketPreviousClose": 1.83, "regularMarketOpen": 1.76, "regularMarketDayLow": 1.66, "regularMarketDayHigh": 1.83, "payoutRatio": 0.0, "beta": 1.241, "forwardPE": -1.4824562, "volume": 1826655, "regularMarketVolume": 1826655, "averageVolume": 1545809, "averageVolume10days": 2107090, "averageDailyVolume10Day": 2107090, "bid": 1.66, "ask": 1.72, "bidSize": 7, "askSize": 9, "marketCap": 185409904, "fiftyTwoWeekLow": 1.66, "fiftyTwoWeekHigh": 7.85, "fiftyDayAverage": 2.8341, "twoHundredDayAverage": 5.095575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -97635392, "profitMargins": 0.0, "floatShares": 81750277, "sharesOutstanding": 109710000, "sharesShort": 11118280, "sharesShortPriorMonth": 10100209, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1013, "heldPercentInsiders": 0.0057599996, "heldPercentInstitutions": 1.07022, "shortRatio": 10.9, "shortPercentOfFloat": 0.1204, "impliedSharesOutstanding": 109710000, "bookValue": 2.68, "priceToBook": 0.630597, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -138200000, "trailingEps": -1.01, "forwardEps": -1.14, "enterpriseToEbitda": 0.643, "52WeekChange": -0.72066116, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 1.69, "targetHighPrice": 20.0, "targetLowPrice": 9.0, "targetMeanPrice": 13.33333, "targetMedianPrice": 12.5, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 312016992, "totalCashPerShare": 2.844, "ebitda": -151923008, "totalDebt": 28972000, "quickRatio": 10.226, "currentRatio": 10.372, "debtToEquity": 9.885, "returnOnAssets": -0.29733, "returnOnEquity": -0.50841, "freeCashflow": -62796624, "operatingCashflow": -118006000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1743810678, "regularMarketTime": 1743796803, "exchange": "NMS", "messageBoardId": "finmb_279883519", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "longName": "Annexon, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1595597400000, "postMarketChangePercent": 0.591715, "postMarketPrice": 1.7, "postMarketChange": 0.00999999, "regularMarketChange": -0.13999999, "regularMarketDayRange": "1.66 - 1.83", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1545809, "fiftyTwoWeekLowChange": 0.03000009, "fiftyTwoWeekLowChangePercent": 0.018072344, "fiftyTwoWeekRange": "1.66 - 7.85", "fiftyTwoWeekHighChange": -6.16, "fiftyTwoWeekHighChangePercent": -0.7847134, "fiftyTwoWeekChangePercent": -72.06612, "earningsTimestamp": 1741006800, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.01, "epsForward": -1.14, "epsCurrentYear": -1.22847, "priceEpsCurrentYear": -1.3756951, "fiftyDayAverageChange": -1.1441, "fiftyDayAverageChangePercent": -0.40369076, "twoHundredDayAverageChange": -3.4055748, "twoHundredDayAverageChangePercent": -0.66833967, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": -7.6502724, "regularMarketPrice": 1.69, "marketState": "CLOSED", "shortName": "Annexon, Inc.", "market": "us_market", "esgPopulated": false, "displayName": "Annexon", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]